Suzanne Romano, PhD
Senior Vice President, Product Evaluation & Early Stage Development
Dr. Romano is responsible for evaluation, preclinical and early clinical development of in-licensed drug candidates sourced from China. Having participated in all aspects of HUYABIO’s in-licensing process, she now leads the Cardiovascular program’s clinical proof of concept trials. With over 20 years experience in drug discovery, corporate partnering, and alliance management in a broad range of therapeutic areas, Suzanne has provided scientific business development consulting services to several biotech companies. She was previously Director of Business Development at Novasite Pharmaceuticals and served in Ontogen Corporation’s corporate development and drug discovery programs and was a member of Johnson & Johnson’s biotechnology product development group. Dr. Romano received a PhD in Biology/Neurobiology from the University of California, San Diego, and an AB in Biology from Princeton University.